Product Images Alfuzosin Hydrochloride Extended Release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Alfuzosin Hydrochloride Extended Release NDC 31722-302 by Camber Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph showing the concentration of Afizosin in plasma over a period of 24 hours. The y-axis shows the concentration in ng/mL and the x-axis shows time in hours.*
This seems to be a table comparing the effectiveness of a placebo treatment to that of Alfuzosin HCl for a certain condition based on a number of patients. The table shows two groups, one with 150 patients receiving Placebo and the other with 151 patients receiving Alfuzosin HCl. The last line shows a result which appears to be indicating that there was no significant difference in the treatment effectiveness between the two groups after 28 days of treatment.*
This is a description of a medication with the name Alfuzosin HCI, available in the form of tablets. It comes in a packaging of 100 tablets, with each tablet having Altuzosin Hydrochloride 10mg. The medication belongs to the family of extended-release tablets, and the patient is advised to consult the package insert for dosage information. It is recommended to store the medication in a tightly sealed container and away from moisture and light, and keep it out of children's reach. The manufacturer of this medication is InvaGen Pharmaceuticals, and it is distributed by Camber Pharmaceuticals in Piscataway, NJ.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.